Molina Healthcare, Inc. (MOH) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Molina Healthcare, Inc. provides managed healthcare services primarily under Medicaid, Medicare, and state insurance Marketplaces. As of June 30, 2025, the company served approximately 5.7 million members across 22 states. The company operates four reportable segments: Medicaid, Medicare, Marketplace, and Other.
Key Financial Metrics
| Metric (in millions) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Total Revenue | $11,427 | $9,880 | $22,574 | $19,811 |
| Premium Revenue | $10,868 | $9,446 | $21,496 | $18,950 |
| Net Income | $255 | $301 | $553 | $602 |
| Diluted EPS | $4.75 | $5.17 | $10.19 | $10.33 |
| Operating Income | $373 | $434 | $806 | $860 |
| Medical Care Ratio (MCR) | 90.4% | 88.6% | 89.8% | 88.6% |
| Long-Term Debt | $3,375 | $2,923 | $3,375 | $2,923 |
| Cash & Investments | $8,809 | $8,987 | $8,809 | $8,987 |
Note: Cash & Investments calculated as Cash ($4,499M) + Investments ($4,310M) as of June 30, 2025.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 15.6% in Q2 2025 compared to Q2 2024, driven by new contract wins, the ConnectiCare acquisition, and rate increases.
- Profitability Decline: Net income decreased 15.3% in Q2 2025 ($255M vs. $301M) and 8.1% YTD. This was primarily due to a higher Medical Care Ratio (MCR) and increased interest expense.
- MCR Deterioration: The consolidated MCR rose to 90.4% in Q2 2025 from 88.6% in the prior year, exceeding the company's long-term target range. This was driven by higher-than-expected medical costs, acuity shifts, and utilization pressures across all segments.
- Interest Expense: Interest expense increased significantly to $48M in Q2 2025 from $28M in Q2 2024, reflecting new borrowings under a Term Loan and Credit Facility.
- Membership: Total membership grew 3.0% to 5.7 million, with significant growth in the Marketplace segment (up 304,000 members) partially offset by a contraction in Medicaid.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted a "very challenging medical cost trend environment" but noted effective cost management and G&A efficiencies (G&A ratio improved to 6.2% from 7.0%). The company emphasized that the MCR is currently above its long-term target range.
Regulatory Risks: The filing discusses the "One Big Beautiful Bill Act" (OBBBA) signed in July 2025, which introduces work requirements and cost-sharing for Medicaid expansion, potentially reducing enrollment by 15-20% in the expansion population. It also notes new HHS rules tightening Marketplace eligibility.
Acquisitions & Contracts:
- ConnectiCare: Acquired for $350M in Q1 2025, adding ~140,000 members in Connecticut.
- New Contracts: Commenced operations in Mississippi (July 2025) and Florida (Feb 2025); awarded contracts in Nevada and Illinois effective Jan 2026.
- Contract Loss: Virginia contracts terminated effective June 30, 2025, following a failed protest of a procurement decision.
Capital Allocation: The company exhausted a $1B share repurchase authorization in Q1 2025. A new $1B repurchase program was authorized in April 2025, extending through Dec 31, 2026.
Investor Verification Checklist
- MCR Sustainability: Verify if the elevated MCR (90.4%) is a temporary anomaly or a structural shift in medical cost trends that could persist through 2025.
- Regulatory Impact: Assess the potential enrollment and revenue impact of the OBBBA work requirements and Medicaid funding changes starting in 2027-2028.
- ConnectiCare Integration: Monitor the integration progress and margin performance of the ConnectiCare acquisition, which contributed to higher initial MCRs in the Marketplace segment.
- Debt Servicing: Review the impact of the new $500M Term Loan and increased interest rates on future cash flows and leverage ratios.
- Virginia Exit: Evaluate the financial impact of the contract termination in Virginia and the success of the new Mississippi and Florida contracts in offsetting this loss.